Teemu D. Laajala

2.1k total citations
44 papers, 987 citations indexed

About

Teemu D. Laajala is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Teemu D. Laajala has authored 44 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Teemu D. Laajala's work include Prostate Cancer Treatment and Research (10 papers), Statistical Methods in Clinical Trials (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Teemu D. Laajala is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Statistical Methods in Clinical Trials (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Teemu D. Laajala collaborates with scholars based in Finland, Sweden and United States. Teemu D. Laajala's co-authors include Tero Aittokallio, Matti Poutanen, Laura L. Elo, Riitta Lahesmaa, Jukka Westermarck, Sari Mäkelä, Soile Tuomela, Sunil K. Raghav, Pekka Haapaniemi and Otto Kauko and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Bioinformatics.

In The Last Decade

Teemu D. Laajala

43 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teemu D. Laajala Finland	17	457	210	178	150	140	44	987
Isabella Gashaw Germany	21	489 1.1×	126 0.6×	281 1.6×	377 2.5×	161 1.1×	41	1.2k
Long Gao China	20	788 1.7×	284 1.4×	269 1.5×	31 0.2×	78 0.6×	60	1.5k
Shun‐Ichiro Kageyama Japan	20	613 1.3×	119 0.6×	179 1.0×	56 0.4×	175 1.3×	52	1.1k
Kasper Langebjerg Andersen Denmark	10	418 0.9×	214 1.0×	53 0.3×	60 0.4×	73 0.5×	17	938
Kaisa Huhtinen Finland	25	645 1.4×	364 1.7×	463 2.6×	865 5.8×	97 0.7×	62	1.8k
Qi Shen China	17	707 1.5×	60 0.3×	85 0.5×	144 1.0×	77 0.6×	41	1.1k
Michael Slifker United States	24	984 2.2×	348 1.7×	389 2.2×	38 0.3×	251 1.8×	54	1.9k
Russell B. Myers United States	24	708 1.5×	245 1.2×	116 0.7×	142 0.9×	342 2.4×	43	1.6k
Justin Y. Newberg United States	21	727 1.6×	122 0.6×	61 0.3×	47 0.3×	294 2.1×	55	1.5k

Countries citing papers authored by Teemu D. Laajala

Since Specialization

Citations

This map shows the geographic impact of Teemu D. Laajala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teemu D. Laajala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teemu D. Laajala more than expected).

Fields of papers citing papers by Teemu D. Laajala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teemu D. Laajala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teemu D. Laajala. The network helps show where Teemu D. Laajala may publish in the future.

Co-authorship network of co-authors of Teemu D. Laajala

This figure shows the co-authorship network connecting the top 25 collaborators of Teemu D. Laajala. A scholar is included among the top collaborators of Teemu D. Laajala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teemu D. Laajala. Teemu D. Laajala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vogt, Andreas, Ilkka Paatero, Klaus Elenius, et al.. (2024). DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer. EMBO Molecular Medicine. 16(7). 1603–1629. 9 indexed citations

Laajala, Teemu D., et al.. (2023). Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy. Clinical Lung Cancer. 24(4). 295–304. 7 indexed citations

Polari, Lauri, Marko Kalliomäki, Teemu D. Laajala, et al.. (2023). The Effect of a Fish Oil and/or Probiotic Intervention from Early Pregnancy Onwards on Colostrum Immune Mediators: A Randomized, Placebo‐Controlled, Double‐Blinded Clinical Trial in Overweight/Obese Mothers. Molecular Nutrition & Food Research. 67(15). e2200446–e2200446. 5 indexed citations

Laajala, Teemu D., et al.. (2023). Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland. BMC Women s Health. 23(1). 242–242. 2 indexed citations

Cvrljevic, Anna N., Kaisa Huhtinen, Tove J. Grönroos, et al.. (2022). Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype. Molecular Cancer Therapeutics. 21(7). 1236–1245. 3 indexed citations

Sipilä, Petra, Riikka Oksala, Matias Knuuttila, et al.. (2022). High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice. iScience. 25(5). 104287–104287. 6 indexed citations

Laajala, Teemu D., et al.. (2021). Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes. Cancers. 13(13). 3272–3272. 15 indexed citations

Mattila, Kalle, Teemu D. Laajala, Tuomas P. Kilpeläinen, et al.. (2021). A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma. Scientific Reports. 11(1). 8650–8650. 5 indexed citations

Airola, Antti, et al.. (2019). Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets. International Journal of Medical Informatics. 133. 104014–104014. 11 indexed citations

10.

Oksala, Riikka, Matias Knuuttila, Arfa Mehmood, et al.. (2018). Adrenals Contribute to Growth of Castration-Resistant VCaP Prostate Cancer Xenografts. American Journal Of Pathology. 188(12). 2890–2901. 18 indexed citations

11.

Erickson, Andrew, Stefano Luzzago, Axel Semjonow, et al.. (2018). Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study. European Urology Oncology. 1(4). 268–275. 6 indexed citations

12.

Huvila, Jutta, Teemu D. Laajala, Per‐Henrik Edqvist, et al.. (2018). Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma. Gynecologic Oncology. 149(1). 173–180. 16 indexed citations

13.

Knuuttila, Matias, Arfa Mehmood, Emrah Yatkin, et al.. (2017). Antiandrogens Reduce Intratumoral Androgen Concentrations and Induce Androgen Receptor Expression in Castration-Resistant Prostate Cancer Xenografts. American Journal Of Pathology. 188(1). 216–228. 10 indexed citations

14.

Bulanova, Daria, Anne Rokka, Teemu D. Laajala, et al.. (2016). Orphan G protein-coupled receptor GPRC5A modulates integrin β1-mediated epithelial cell adhesion. Cell Adhesion & Migration. 11(5-6). 434–446. 16 indexed citations

15.

Kauko, Otto, Teemu D. Laajala, Petteri Hintsanen, et al.. (2015). Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling. Scientific Reports. 5(1). 13099–13099. 46 indexed citations

16.

Knuuttila, Matias, Emrah Yatkin, Teemu D. Laajala, et al.. (2014). Castration Induces Up-Regulation of Intratumoral Androgen Biosynthesis and Androgen Receptor Expression in an Orthotopic VCaP Human Prostate Cancer Xenograft Model. American Journal Of Pathology. 184(8). 2163–2173. 53 indexed citations

17.

Muth‐Pawlak, Dorota, Kaisa Huhtinen, Kimmo Jaakkola, et al.. (2014). Ovarian Endometriosis Signatures Established through Discovery and Directed Mass Spectrometry Analysis. Journal of Proteome Research. 13(11). 4983–4994. 13 indexed citations

18.

Yatkin, Emrah, Lauri Polari, Teemu D. Laajala, et al.. (2014). Novel Lignan and Stilbenoid Mixture Shows Anticarcinogenic Efficacy in Preclinical PC-3M-luc2 Prostate Cancer Model. PLoS ONE. 9(4). e93764–e93764. 30 indexed citations

19.

Kallionpää, Henna, Laura L. Elo, Essi Laajala, et al.. (2014). Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility. Diabetes. 63(7). 2402–2414. 132 indexed citations

20.

Laajala, Teemu D., Jukka Corander, Niina Saarinen, et al.. (2012). Improved Statistical Modeling of Tumor Growth and Treatment Effect in Preclinical Animal Studies with Highly Heterogeneous Responses In Vivo. Clinical Cancer Research. 18(16). 4385–4396. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact